Opinion: Should Science Be for Sale?

The increasing push to commercialize research is destroying the scientific community.

Written byVictoria Doronina
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIAI was born in the USSR and now work as a postdoc at University of Manchester in the United Kingdom. Once, my PI and I were returning to a hotel after dinner with our collaborators in a different UK city, where one of the postdocs had the same post-Soviet background as me. My boss commented that there seems to be a lot of people of Soviet extraction working in Western science and joked that we are close to taking over it. I replied that he doesn’t have to worry; the supply of Soviet scientists is gone, never to be replaced.

After the demise of the USSR in 1991, science in the former Soviet Republics lost most of its funding, and as a result, most scientists lost their once-prestigious, middle-income jobs. The prevailing mood of the society changed; most of the population, including many scientists, decided that the only thing that mattered in life was earning money—fast. Many academics, such as Russian billionaire Boris Berezovsky, a former department head at The Institute of Systems Control of the Russian Academy of Sciences, changed their careers, leaving old professors and young PhD students alone in the lab. Without their mentors, many young researchers who actually cared about science abandoned their home universities for work in the West.

Fast forward 20 years: the devaluing of the pursuit of knowledge ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies